683 Capital Management’s Bioventus BVS Stock Holding History

683 Capital Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-56,389	Closed	-$297K	–	158
2023 Q4	$297K	Buy	+56,389	New	+$223K	0.02%	118

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

683 Capital Management's BVS Position: Q1 2024 in Review

683 Capital Management sold out of Bioventus (BVS) in Q1 2024, closing a stake of 56,389 shares — an estimated $297K sold.

683 Capital Management first reported a position in BVS in Q4 2023 and held it in 1 quarter. The position peaked at $297K in Q4 2023. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

683 Capital Management reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
683 Capital Management sold 56,389 Bioventus shares in Q1 2024, an estimated $297K.
683 Capital Management first reported a position in Bioventus in Q4 2023 and held it in 1 quarter.
683 Capital Management's Bioventus position peaked at $297K in Q4 2023.
84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on 683 Capital Management's 13F filing for Q1 2024, filed 15 May 2024.